This website is intended for healthcare professionals only.

Hospital Pharmacy Europe     Newsletter          

*** Editor’s Pick

Syfovre approved for geographic atrophy in advanced age-related macular degeneration
Syfovre approved for geographic atrophy in advanced age-related macular degeneration
Read more
Pregnancy hypertensive disorders linked to higher future risk of cardiovascular disease
Pregnancy hypertensive disorders linked to higher future risk of cardiovascular disease
Read more
Pembrolizumab shows benefit in high-risk BCG non-responsive bladder cancer
Pembrolizumab shows benefit in high-risk BCG non-responsive bladder cancer
Read more
Tracking the anticholinergic burden score during hospital admission in acute care
Tracking the anticholinergic burden score during hospital admission in acute care
Read more
Hemgenix<sup>®</sup> first gene therapy approved in EU for haemophilia B
Hemgenix® first gene therapy approved in EU for haemophilia B
Read more
Fetal alcohol spectrum disorders: An overview
Fetal alcohol spectrum disorders: An overview
Read more
Darolutamide improves overall survival in metastatic hormone sensitive prostate cancer
Darolutamide improves overall survival in metastatic hormone sensitive prostate cancer
Read more
Medicines optimisation for the frail older person
Medicines optimisation for the frail older person
Read more
Optimising physical health in individuals with severe mental illness and the role of pharmacy
Optimising physical health in individuals with severe mental illness and the role of pharmacy
Read more
Neoadjuvant nivolumab provides significant 5-year overall survival in lung cancer
Neoadjuvant nivolumab provides significant 5-year overall survival in lung cancer
Read more
Study reveals significant increase in hospital admissions for COPD and asthma
Study reveals significant increase in hospital admissions for COPD and asthma
Read more
Several autoimmune diseases associated with increased risk of atrial fibrillation
Several autoimmune diseases associated with increased risk of atrial fibrillation
Read more
GLP-1 agonists associated with modest weight loss in real-world setting
GLP-1 agonists associated with modest weight loss in real-world setting
Read more
RCT shows Ide-cel effective in refractory or relapsed multiple myeloma
RCT shows Ide-cel effective in refractory or relapsed multiple myeloma
Read more
Study evaluates the effectiveness and safety of prescribing pharmacists in care homes
Study evaluates the effectiveness and safety of prescribing pharmacists in care homes
Read more

Popular articles

Exacerbations reduced by dupilumab in COPD patients with type 2 inflammation
Biobank pilot to be launched by MHRA to better understand genetics and medicines safety
Government commits to easing pressure on NHS through commercial clinical trial investment





 

Download Hospital Healthcare Europe free app

Download our app from the Apple App Store Download our app from Google Play

In official association with

HOPE Logo Footer

© Cogora 2023
Cogora Limited. 1 Giltspur Street, London EC1A 9DD Registered in the United Kingdom. Reg. No. 2147432

Cogora